Gutwin 400 Tablet contains Rifaximin 400 mg, a broad-spectrum, non-absorbable antibiotic primarily used to treat gastrointestinal infections. Rifaximin acts locally within the gut by inhibiting bacterial RNA synthesis, targeting a wide range of gram-positive and gram-negative aerobic and anaerobic bacteria. This medication is indicated for the treatment of travelers’ diarrhea caused by non-invasive strains of Escherichia coli, hepatic encephalopathy prevention by reducing ammonia-producing gut bacteria, and irritable bowel syndrome with diarrhea (IBS-D). Due to its minimal systemic absorption, Gutwin 400 exhibits a favorable safety profile with limited systemic side effects. It is administered orally, with dosing regimens varying according to the specific indication and severity of the condition. Caution is advised in patients with hypersensitivity to rifamycin derivatives and in those with severe liver impairment. Common adverse effects may include nausea, abdominal pain, and headache, though these are generally mild and transient. Gutwin 400 should be used under medical supervision, ensuring appropriate diagnosis and monitoring for therapeutic efficacy and potential adverse reactions. It is contraindicated in patients with known hypersensitivity to rifaximin or any of its excipients. This medication should be stored at room temperature, away from moisture and heat.